Patent details

EP2089423 Title: ANTIGEN SPECIFIC MULTI EPITOPE VACCINES

Basic Information

Publication number:
EP2089423
PCT Application Number:
PCT/IL/2007/001168
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP078271434
PCT Publication Number:
WO/2008/035350
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTIGEN SPECIFIC MULTI EPITOPE VACCINES
French Title of Invention:
VACCINS À MULTIPLES ÉPITOPES SPÉCIFIQUES À UN ANTIGÈNE
German Title of Invention:
ANTIGENSPEZIFISCHE MULTI-EPITOP-IMPFSTOFFE
SPC Number:

Dates

Filing date:
23/09/2007
Grant date:
26/10/2016
EP Publication Date:
26/10/2016
PCT Publication Date:
27/03/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/08/2009
EP B1 Publication Date:
26/10/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/09/2017
Expiration date:
23/09/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/09/2007
 
 

Name:
Vaxil Biotherapeutics Ltd.
Address:
Building 13A Weizmann Science Park, 76120 Rehovot, Israel (IL)

Inventor

Name:
CARMON Lior
Address:
Israel (IL)

Priority

Priority Number:
846087 P
Priority Date:
21/09/2006
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 14/47;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages